Clinical Trial Update: Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study [Phase 4]

View source ↗

Summary

A Phase 4 trial compares alternative pomalidomide dosing schedules (4 mg every other day vs 2 mg and 4 mg daily) in relapsed/refractory multiple myeloma, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Multiple Myeloma in Relapse, Multiple Myeloma | Phase 4 | Status: COMPLETED